Growth Inhibitory Effects of Three MiR-129 Family Members on Gastric Cancer
Overview
Affiliations
Reduced expression of microRNA-129 (miR-129) has been reported in several types of tumor cell lines as well as in primary tumor tissues. However, little is known about how miR-129 affects cell proliferation in gastric cancer. Here, we show that all miR-129 family members, miR-129-1-3p, miR-129-2-3p, and miR-129-5p, are down-regulated in gastric cancer cell lines compared with normal gastric epithelial cells. Furthermore, using the real-time cell analyzer assay to observe the growth effects of miR-129 on gastric cancer cells, we found that all three mature products of miR-129 showed tumor suppressor activities. To elucidate the molecular mechanisms underlying down-regulation of miR-129 in gastric cancer, we analyzed the effects of miR-129 mimics on the cell cycle. We found that increased miR-129 levels in gastric cancer cells resulted in significant G0/G1 phase arrest. Interestingly, we showed that cyclin dependent kinase 6 (CDK6), a cell cycle-associated protein involved in G1-S transition, was a target of miR-129. We also found that expression of the sex determining region Y-box 4 (SOX4) was inversely associated with that of miR-129-2-3p and miR-129-5p but not of miR-129-1-3p. Together, our data indicate that all miR-129 family members, not only miR-129-5p, as previously thought, play an important role in regulating cell proliferation in gastric cancer.
Potential Regulation of by miR-129-5p and miR-3613-3p and Their Prognostic Value in Gastric Cancer.
Bure I, Vetchinkina E, Kalinkin A, Kuznetsova E, Molchanov A, Kiseleva A Int J Mol Sci. 2025; 26(1.
PMID: 39796161 PMC: 11719569. DOI: 10.3390/ijms26010305.
Zhu Z, Xie Y, Yin M, Peng L, Zhu H J Cancer. 2024; 15(18):6086-6102.
PMID: 39440054 PMC: 11493006. DOI: 10.7150/jca.99173.
Abdolahi F, Shahraki A, Sheervalilou R, Mortazavi S BMC Med Genomics. 2023; 16(1):311.
PMID: 38041130 PMC: 10690994. DOI: 10.1186/s12920-023-01720-7.
Ye Y, Lin Y, Chi Z, Zhang J, Cai F, Zhu Y PeerJ. 2022; 10:e14257.
PMID: 36312756 PMC: 9610657. DOI: 10.7717/peerj.14257.
Targeted MicroRNA Profiling in Gastric Cancer with Clinical Assessement.
Pehlevan Ozel H, Dinc T, Tiryaki R, Keskus A, Konu O, Kayilioglu S Balkan J Med Genet. 2022; 24(2):55-64.
PMID: 36249523 PMC: 9524170. DOI: 10.2478/bjmg-2021-0022.